PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
PurposeProstate-specific membrane antigen (PSMA) is a cell surface protein with high expression in prostate carcinoma (PC) cells. Recently, procedures have been developed to label PSMA ligands with 68Ga, 99mTc and 123/124/131I. Our initial experience with Glu-NH-CO-NH-Lys-(Ahx)-[68Ga(HBED-CC)](68Ga-...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2013
|
| In: |
European journal of nuclear medicine and molecular imaging
Year: 2012, Volume: 40, Issue: 4, Pages: 486-495 |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-012-2298-2 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1007/s00259-012-2298-2 Verlag, Volltext: https://link.springer.com/article/10.1007/s00259-012-2298-2 
|
| Author Notes: | A. Afshar-Oromieh, A. Malcher, M. Eder, M. Eisenhut, H.G. Linhart, BA.. Hadaschik, T. Holland-Letz, F.L. Giesel, C. Kratochwil, S. Haufe, U. Haberkorn, C.M. Zechmann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1572152060 | ||
| 003 | DE-627 | ||
| 005 | 20230426124247.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180419r20132012xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00259-012-2298-2 |2 doi | |
| 035 | |a (DE-627)1572152060 | ||
| 035 | |a (DE-576)502152060 | ||
| 035 | |a (DE-599)BSZ502152060 | ||
| 035 | |a (OCoLC)1341007356 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Afshar-Oromieh, Ali |d 1975- |e VerfasserIn |0 (DE-588)130260436 |0 (DE-627)496579711 |0 (DE-576)189580003 |4 aut | |
| 245 | 1 | 0 | |a PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer |b biodistribution in humans and first evaluation of tumour lesions |c A. Afshar-Oromieh, A. Malcher, M. Eder, M. Eisenhut, H.G. Linhart, BA.. Hadaschik, T. Holland-Letz, F.L. Giesel, C. Kratochwil, S. Haufe, U. Haberkorn, C.M. Zechmann |
| 246 | 3 | 3 | |a PET imaging with a [68 Ga] gallium-labelled PSMA ligand for the diagnosis of prostate cancer |
| 264 | 1 | |c 2013 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Im Titel ist die Zahl 68 hochgestellt | ||
| 500 | |a Published online: 24 November 2012 | ||
| 500 | |a Gesehen am 13.12.2018 | ||
| 520 | |a PurposeProstate-specific membrane antigen (PSMA) is a cell surface protein with high expression in prostate carcinoma (PC) cells. Recently, procedures have been developed to label PSMA ligands with 68Ga, 99mTc and 123/124/131I. Our initial experience with Glu-NH-CO-NH-Lys-(Ahx)-[68Ga(HBED-CC)](68Ga-PSMA) suggests that this novel tracer can detect PC relapses and metastases with high contrast. The aim of this study was to investigate its biodistribution in normal tissues and tumour lesions.MethodsA total of 37 patients with PC and rising prostate-specific antigen (PSA) levels were subjected to 68Ga-PSMA positron emission tomography (PET)/CT. Quantitative assessment of tracer uptake was performed 1 and 3 h post-injection (p.i.) by analysis of mean and maximum standardized uptake values (SUVmean/max) of several organs and 65 tumour lesions. Subsequently, tumour to background ratios were calculated.ResultsThe PET/CT images showed intense tracer uptake in both kidneys and salivary glands. Moderate uptake was seen in lacrimal glands, liver, spleen and in small and large bowel. Quantitative assessment revealed excellent contrast between tumour lesions and most normal tissues. Of 37 patients, 31 (83.8 %) showed at least one lesion suspicious for cancer at a detection rate of 60 % at PSA <2.2 ng/ml and 100 % at PSA >2.2 ng/ml. Median tumour to background ratios were 18.8 (2.4-158.3) in early images and 28.3 (2.9-224.0) in late images.ConclusionThe biodistribution of the novel 68Ga-PSMA tracer and its ability to detect PC lesions was analysed in 37 patients. Within healthy organs, kidneys and salivary glands demonstrated the highest radiotracer uptake. Lesions suspicious for PC presented with excellent contrast as early as 1 h p.i. with high detection rates even at low PSA levels. | ||
| 534 | |c 2012 | ||
| 700 | 1 | |a Malcher, Anna |d 1988- |e VerfasserIn |0 (DE-588)1049918487 |0 (DE-627)782883818 |0 (DE-576)403909511 |4 aut | |
| 700 | 1 | |a Eder, Matthias |d 1979- |e VerfasserIn |0 (DE-588)140263217 |0 (DE-627)616969279 |0 (DE-576)316151092 |4 aut | |
| 700 | 1 | |a Eisenhut, Michael |e VerfasserIn |0 (DE-588)1113306122 |0 (DE-627)867174501 |0 (DE-576)160846080 |4 aut | |
| 700 | 1 | |a Hadaschik, Boris |d 1974- |e VerfasserIn |0 (DE-588)124300553 |0 (DE-627)085770930 |0 (DE-576)294109013 |4 aut | |
| 700 | 1 | |a Giesel, Frederik L. |d 1970- |e VerfasserIn |0 (DE-588)129031240 |0 (DE-627)387883878 |0 (DE-576)297457071 |4 aut | |
| 700 | 1 | |a Kratochwil, Clemens |d 1978- |e VerfasserIn |0 (DE-588)134026276 |0 (DE-627)559871686 |0 (DE-576)300262787 |4 aut | |
| 700 | 1 | |a Haufe, Sabine |e VerfasserIn |0 (DE-588)1032764899 |0 (DE-627)739277200 |0 (DE-576)380272318 |4 aut | |
| 700 | 1 | |a Haberkorn, Uwe |d 1959- |e VerfasserIn |0 (DE-588)1022913905 |0 (DE-627)717331245 |0 (DE-576)366166352 |4 aut | |
| 700 | 1 | |a Zechmann, Christian |d 1972- |e VerfasserIn |0 (DE-588)128951443 |0 (DE-627)486911780 |0 (DE-576)187772096 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of nuclear medicine and molecular imaging |d Heidelberg [u.a.] : Springer-Verl., 2002 |g 40(2013), 4, Seite 486-495 |h Online-Ressource |w (DE-627)359787258 |w (DE-600)2098375-X |w (DE-576)110279549 |x 1619-7089 |7 nnas |a PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer biodistribution in humans and first evaluation of tumour lesions |
| 773 | 1 | 8 | |g volume:40 |g year:2013 |g number:4 |g pages:486-495 |g extent:10 |a PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer biodistribution in humans and first evaluation of tumour lesions |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00259-012-2298-2 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00259-012-2298-2 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180419 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 128951443 |a Zechmann, Christian |m 128951443:Zechmann, Christian |d 910000 |d 911400 |e 910000PZ128951443 |e 911400PZ128951443 |k 0/910000/ |k 1/910000/911400/ |p 12 |y j | ||
| 998 | |g 1022913905 |a Haberkorn, Uwe |m 1022913905:Haberkorn, Uwe |d 910000 |d 911400 |e 910000PH1022913905 |e 911400PH1022913905 |k 0/910000/ |k 1/910000/911400/ |p 11 | ||
| 998 | |g 1032764899 |a Haufe, Sabine |m 1032764899:Haufe, Sabine |d 910000 |d 911400 |e 910000PH1032764899 |e 911400PH1032764899 |k 0/910000/ |k 1/910000/911400/ |p 10 | ||
| 998 | |g 134026276 |a Kratochwil, Clemens |m 134026276:Kratochwil, Clemens |d 910000 |d 911400 |e 910000PK134026276 |e 911400PK134026276 |k 0/910000/ |k 1/910000/911400/ |p 9 | ||
| 998 | |g 129031240 |a Giesel, Frederik L. |m 129031240:Giesel, Frederik L. |d 910000 |d 911400 |e 910000PG129031240 |e 911400PG129031240 |k 0/910000/ |k 1/910000/911400/ |p 8 | ||
| 998 | |g 124300553 |a Hadaschik, Boris |m 124300553:Hadaschik, Boris |d 910000 |d 911400 |e 910000PH124300553 |e 911400PH124300553 |k 0/910000/ |k 1/910000/911400/ |p 6 | ||
| 998 | |g 1113306122 |a Eisenhut, Michael |m 1113306122:Eisenhut, Michael |d 50000 |e 50000PE1113306122 |k 0/50000/ |p 4 | ||
| 998 | |g 140263217 |a Eder, Matthias |m 140263217:Eder, Matthias |p 3 | ||
| 998 | |g 1049918487 |a Malcher, Anna |m 1049918487:Malcher, Anna |d 910000 |d 911400 |e 910000PM1049918487 |e 911400PM1049918487 |k 0/910000/ |k 1/910000/911400/ |p 2 | ||
| 998 | |g 130260436 |a Afshar-Oromieh, Ali |m 130260436:Afshar-Oromieh, Ali |d 910000 |d 911400 |e 910000PA130260436 |e 911400PA130260436 |k 0/910000/ |k 1/910000/911400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1572152060 |e 300643272X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1572152060","origin":[{"dateIssuedDisp":"2013","dateIssuedKey":"2013"}],"name":{"displayForm":["A. Afshar-Oromieh, A. Malcher, M. Eder, M. Eisenhut, H.G. Linhart, BA.. Hadaschik, T. Holland-Letz, F.L. Giesel, C. Kratochwil, S. Haufe, U. Haberkorn, C.M. Zechmann"]},"person":[{"display":"Afshar-Oromieh, Ali","given":"Ali","family":"Afshar-Oromieh","role":"aut"},{"display":"Malcher, Anna","given":"Anna","family":"Malcher","role":"aut"},{"display":"Eder, Matthias","given":"Matthias","family":"Eder","role":"aut"},{"given":"Michael","display":"Eisenhut, Michael","family":"Eisenhut","role":"aut"},{"role":"aut","display":"Hadaschik, Boris","given":"Boris","family":"Hadaschik"},{"family":"Giesel","given":"Frederik L.","display":"Giesel, Frederik L.","role":"aut"},{"family":"Kratochwil","given":"Clemens","display":"Kratochwil, Clemens","role":"aut"},{"given":"Sabine","display":"Haufe, Sabine","family":"Haufe","role":"aut"},{"family":"Haberkorn","given":"Uwe","display":"Haberkorn, Uwe","role":"aut"},{"role":"aut","family":"Zechmann","given":"Christian","display":"Zechmann, Christian"}],"titleAlt":[{"title":"PET imaging with a [68 Ga] gallium-labelled PSMA ligand for the diagnosis of prostate cancer"}],"language":["eng"],"title":[{"title":"PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer","title_sort":"PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer","subtitle":"biodistribution in humans and first evaluation of tumour lesions"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1572152060"],"doi":["10.1007/s00259-012-2298-2"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["29.2002 -"],"language":["eng"],"recId":"359787258","disp":"PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer biodistribution in humans and first evaluation of tumour lesionsEuropean journal of nuclear medicine and molecular imaging","note":["Gesehen am 13.02.2023","Ungezählte Beil.: Supplement"],"part":{"extent":"10","issue":"4","year":"2013","pages":"486-495","volume":"40","text":"40(2013), 4, Seite 486-495"},"id":{"zdb":["2098375-X"],"issn":["1619-7089"],"eki":["359787258"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"European journal of nuclear medicine and molecular imaging","title_sort":"European journal of nuclear medicine and molecular imaging","subtitle":"official journal of the European Association of Nuclear Medicine (EANM)"}],"origin":[{"dateIssuedDisp":"2002-","publisher":"Springer-Verl.","publisherPlace":"Heidelberg [u.a.]","dateIssuedKey":"2002"}]}],"note":["Im Titel ist die Zahl 68 hochgestellt","Published online: 24 November 2012","Gesehen am 13.12.2018"]} | ||
| SRT | |a AFSHAROROMPETIMAGING2013 | ||